ConductScience.org, home

Trial · NCT03122860

Results by group54

Each measurement the trial posted, group by group, in the words and numbers it posted.

OutcomeGroupCategoryValueSpreadUnits
Change From Baseline in Medial Joint Space Width (mJSW) of the Target Knee0.15 mg SM04690-0.11Standard Deviation 0.92mm
Change From Baseline in Medial Joint Space Width (mJSW) of the Target Knee0.23 mg SM04690-0.03Standard Deviation 0.45mm
Change From Baseline in Medial Joint Space Width (mJSW) of the Target KneePlacebo-0.01Standard Deviation 0.60mm
Change From Baseline in Medial Joint Space Width (mJSW) of the Target KneeSham-0.08Standard Deviation 0.58mm
Change From Baseline OA Disease Activity as Assessed by Patient Global Assessment (PtGA)0.03 mg SM04690-16.0Standard Deviation 23.5mm
Change From Baseline OA Disease Activity as Assessed by Patient Global Assessment (PtGA)0.07 mg SM04690-19.8Standard Deviation 27.1mm
Change From Baseline OA Disease Activity as Assessed by Patient Global Assessment (PtGA)0.15 mg SM04690-11.9Standard Deviation 27.5mm
Change From Baseline OA Disease Activity as Assessed by Patient Global Assessment (PtGA)0.23 mg SM04690-18.3Standard Deviation 24.5mm
Change From Baseline OA Disease Activity as Assessed by Patient Global Assessment (PtGA)Placebo-13.0Standard Deviation 21.6mm
Change From Baseline OA Disease Activity as Assessed by Patient Global Assessment (PtGA)Sham-13.8Standard Deviation 24.4mm
Change From Baseline OA Pain in the Target Knee as Assessed by WOMAC Pain Subscore (WOMAC Pain)0.03 mg SM04690-25.8Standard Deviation 20.5score on a scale
Change From Baseline OA Pain in the Target Knee as Assessed by WOMAC Pain Subscore (WOMAC Pain)0.07 mg SM04690-29.3Standard Deviation 21.5score on a scale
Change From Baseline OA Pain in the Target Knee as Assessed by WOMAC Pain Subscore (WOMAC Pain)0.15 mg SM04690-22.1Standard Deviation 20.2score on a scale
Change From Baseline OA Pain in the Target Knee as Assessed by WOMAC Pain Subscore (WOMAC Pain)0.23 mg SM04690-32.1Standard Deviation 21.2score on a scale
Change From Baseline OA Pain in the Target Knee as Assessed by WOMAC Pain Subscore (WOMAC Pain)Placebo-23.7Standard Deviation 24.6score on a scale
Change From Baseline OA Pain in the Target Knee as Assessed by WOMAC Pain Subscore (WOMAC Pain)Sham-22.8Standard Deviation 23.2score on a scale
Change From Baseline OA Function in the Target Knee as Assessed by WOMAC Physical Function Subscore (WOMAC Function)0.03 mg SM04690-26.0Standard Deviation 19.0score on a scale
Change From Baseline OA Function in the Target Knee as Assessed by WOMAC Physical Function Subscore (WOMAC Function)0.07 mg SM04690-29.3Standard Deviation 21.8score on a scale
Change From Baseline OA Function in the Target Knee as Assessed by WOMAC Physical Function Subscore (WOMAC Function)0.15 mg SM04690-20.9Standard Deviation 20.2score on a scale
Change From Baseline OA Function in the Target Knee as Assessed by WOMAC Physical Function Subscore (WOMAC Function)0.23 mg SM04690-30.4Standard Deviation 21.3score on a scale

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03122860/results?page=2